Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer's Disease and Non-Demented Individuals

被引:7
|
作者
Zhang, Xiaoyu [1 ,2 ]
Liu, Yan [1 ,2 ]
Huang, Ming [1 ,2 ]
Gunewardena, Sumedha [1 ]
Haeri, Mohammad [3 ,4 ]
Swerdlow, Russell H. [3 ,4 ,5 ,6 ]
Wang, Ning [1 ,2 ]
机构
[1] Univ Kansas, Dept Cell Biol & Physiol, Med Ctr, Kansas City, KS USA
[2] Inst Reprod & Dev Sci, Kansas City, KS USA
[3] Univ Kansas, Alzheimers Dis Ctr, Kansas City, KS USA
[4] Univ Kansas, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS USA
[5] Univ Kansas, Dept Neurol, Med Ctr, Kansas City, KS USA
[6] Univ Kansas, Dept Biochem & Mol Biol, Med Ctr, Kansas City, KS USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; DNA damage; double-strand DNA breaks; expression regulation; gene; genome instability; COGNITIVE DECLINE; DAMAGE; DEFICIENCY; PRDM9; NEURODEGENERATION; PHOSPHORYLATION; GAMMA-H2AX; HOTSPOTS; GENE; H2AX;
D O I
10.3233/JAD-230316
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Alzheimer's disease (AD) brains accumulate DNA double-strand breaks (DSBs), which could contribute to neurodegeneration and dysfunction. The genomic distribution of AD brain DSBs is unclear. Objective: To map genome-wide DSB distributions in AD and age-matched control brains. Methods: We obtained autopsy brain tissue from 3 AD and 3 age-matched control individuals. The donors were men between the ages of 78 to 91. Nuclei extracted from frontal cortex tissue were subjected to Cleavage Under Targets & Release Using Nuclease (CUT&RUN) assay with an antibody against gamma H2AX, a marker of DSB formation. gamma H2AX-enriched chromatins were purified and analyzed via high-throughput genomic sequencing. Results: The AD brains contained 18 times more DSBs than the control brains and the pattern of AD DSBs differed from the control brain pattern. In conjunction with published genome, epigenome, and transcriptome analyses, our data revealed aberrant DSB formation correlates with AD-associated single-nucleotide polymorphisms, increased chromatin accessibility, and upregulated gene expression. Conclusion: Our data suggest in AD, an accumulation of DSBs at ectopic genomic loci could contribute to an aberrant upregulation of gene expression.
引用
收藏
页码:519 / 535
页数:17
相关论文
共 50 条
  • [21] APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brains
    Joseph O. Ojo
    Jon M. Reed
    Gogce Crynen
    Prashanthi Vallabhaneni
    James Evans
    Benjamin Shackleton
    Maximillian Eisenbaum
    Charis Ringland
    Anastasia Edsell
    Michael Mullan
    Fiona Crawford
    Corbin Bachmeier
    Molecular Brain, 14
  • [22] APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains
    Ojo, Joseph O.
    Reed, Jon M.
    Crynen, Gogce
    Vallabhaneni, Prashanthi
    Evans, James
    Shackleton, Benjamin
    Eisenbaum, Maximillian
    Ringland, Charis
    Edsell, Anastasia
    Mullan, Michael
    Crawford, Fiona
    Bachmeier, Corbin
    MOLECULAR BRAIN, 2021, 14 (01)
  • [23] Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals
    Lorenzini, Luigi
    Collij, Lyduine E.
    Tesi, Niccolo
    Vilor-Tejedor, Natalia
    Ingala, Silvia
    Blennow, Kaj
    Foley, Christopher
    Frisoni, Giovanni B.
    Haller, Sven
    Holstege, Henne
    van der van der Lee, Sven
    Martinez-Lage, Pablo
    Marioni, Riccardo E.
    McCartney, Daniel L.
    O' Brien, John
    Oliveira, Tiago Gil
    Payoux, Pierre
    Reinders, Marcel
    Ritchie, Craig
    Scheltens, Philip
    Schwarz, Adam J.
    Sudre, Carole H.
    Waldman, Adam D.
    Wolz, Robin
    Chatelat, Gael
    Ewers, Michael
    Wink, Alle Meije
    Mutsaerts, Henk J. M. M.
    Gispert, Juan Domingo
    Visser, Pieter Jelle
    Tijms, Betty M.
    Altmann, Andre
    Barkhof, Frederik
    ALZHEIMERS & DEMENTIA, 2024, 20 (09) : 6146 - 6160
  • [24] Expression Profiles of Cytokines in the Brains of Alzheimer's Disease (AD) Patients Compared to the Brains of Non-Demented Patients with and without Increasing AD Pathology
    Morimoto, Kaori
    Horio, Juri
    Satoh, Haruhisa
    Sue, Lucia
    Beach, Thomas
    Arita, Seizaburo
    Tooyama, Ikuo
    Konishi, Yoshihiro
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (01) : 59 - 76
  • [25] CSF Biomarkers in Non-demented Adults at Risk for Alzheimer's Disease.
    Ali, M.
    Barnet, J.
    Zetterberg, H.
    Johnson, S. C.
    Blennow, K.
    Gleason, C. E.
    Hermann, B. P.
    Blazel, H. M.
    Dowling, N.
    Puglielli, L.
    Sager, M. A.
    Asthana, S.
    Carlsson, C. M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 181 - 181
  • [26] ASCVD RISK SCORE IN NON-DEMENTED ADULTS AT RISK FOR ALZHEIMER'S DISEASE
    Chin, N.
    Austin, B.
    Jacobson, L.
    Johnson, S.
    Gleason, C.
    Oh, J.
    Illingworth, C.
    Chappell, R.
    Zetterberg, H.
    Blennow, K.
    Asthana, S.
    Carlsson, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S132 - S132
  • [27] The APOE gene and cognitive function in non-demented and Alzheimer's disease patients
    Payton, Antony
    REVIEWS IN CLINICAL GERONTOLOGY, 2009, 19 (03) : 159 - 169
  • [28] Genetic Risk of Alzheimer's Disease and Sleep Duration in Non-Demented Elders
    Leng, Yue
    Ackley, Sarah F.
    Glymour, Maria M.
    Yaffe, Kristine
    Brenowitz, Willa D.
    ANNALS OF NEUROLOGY, 2021, 89 (01) : 177 - 181
  • [29] EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease
    Ponomareva, N. V.
    Korovaitseva, G. I.
    Rogaev, E. I.
    NEUROBIOLOGY OF AGING, 2008, 29 (06) : 819 - 827
  • [30] Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies
    Zolochevska, Olga
    Taglialatela, Giulio
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (26) : 4063 - 4068